Cochlear Limited
-
Press Releases
Cochlear introduces the new Osia® 3 Sound Processor
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new Cochlear® Osia® 3 Sound Processor the newest advancement of the award-winning Osia System.‡ Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). The Osia 3 Sound Processor is the first fully rechargeable…
Read More » -
Press Releases
Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound Processor and the new non-surgical Baha SoundBand™. Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). Baha 7 Sound Processor in…
Read More » -
Press Releases
FDA approves new cochlear implant with easier access to MRI and expanded connectivity ready for Google’s direct streaming to Android smartphones
CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration’s (FDA) approval of the new Cochlear™ Nucleus®Profile™ Plus Series Cochlear Implant and the Nucleus 7 Sound Processor’s new built-in connectivity featuring direct streaming with compatible Android™ smartphones. FDA approves the new Cochlear Nucleus Profile Plus Series Cochlear Implant. With…
Read More »